nor-NOHA acetate

CAS No. 1140844-63-8

nor-NOHA acetate( Nω-Hydroxy-nor-L-arginine acetate )

Catalog No. M26337 CAS No. 1140844-63-8

nor-NOHA acetate is a reversible inhibitor of arginase, with anti-leukemic activity, effective in endothelial dysfunction, immunosuppression, and metabolism.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
10MG 299 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    nor-NOHA acetate
  • Note
    Research use only, not for human use.
  • Brief Description
    nor-NOHA acetate is a reversible inhibitor of arginase, with anti-leukemic activity, effective in endothelial dysfunction, immunosuppression, and metabolism.
  • Description
    nor-NOHA acetate is a reversible inhibitor of arginase, with anti-leukemic activity, effective in endothelial dysfunction, immunosuppression, and metabolism.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Nω-Hydroxy-nor-L-arginine acetate
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Gram-positive Bacterial| HSV
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1140844-63-8
  • Formula Weight
    296.28
  • Molecular Formula
    C9H20N4O7
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?H2O : 200 mg/mL (675.04 mM)
  • SMILES
    CC(O)=O.CC(O)=O.N[C@@H](CCNC(=N)NO)C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Chan WY, et al. In vitro antimicrobial activity of seven adjuvants against common pathogens associated with canine otitis externa.Vet Dermatol. 2019 Apr;30(2):133-e38.
molnova catalog
related products
  • BFC1108

    BFC1108 targets Bcl-2 and converts it to a pro-apoptotic protein, inhibits the growth of triple-negative breast cancer xenografts with high Bcl-2 expression, inhibits breast cancer lung metastasis, and induces apoptosis of Bcl-2-expressing cancer cells.

  • BiP inducer X

    BiP inducer X is a selective inducer of immunoglobulin heavy chain binding protein (BiP)/GRP78 and an ER chaperone inducer. BiP inducer X prevents cell death in neurons and retinal cell lines.

  • AAPK-25

    AAPK-25, a potent and selective dual inhibitor of Aurora/PLK, causes mitotic delay and cell arrest in prometaphase, via phosphorylation of the biomarker histone H3Ser10, followed by a surge in apoptosis.